glp-1/gip agonists Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Targeting GLP-1, GIP & GCG

5 Discussion GLP-1RAs have emerged as a paradigm-shifting class of agents, with therapeutic benefits that extend well beyond glycemic control in type 2 diabetes

Weight loss is a complex medical process that should always involve professional guidance

The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review

Graham et al., 2020)

[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Angarita GA, Matuskey D, Pittman B, Costeines JL, Potenza MN, Jastreboff AM, et al

(44) reported that both GIPR agonist (GIPRA) and dual GIP/GLP-1 receptor agonist similarly improved glucose tolerance in GLP-1R knockout mice, but not in dual incretin receptor knockout mice